MicroRNA in non-melanoma skin cancer

Cancer Biomarkers

Volumn 11, Issue 6, 2012, Pages 253-257

  Sand, Michael ^a   Sand, Daniel ^b   Altmeyer, Peter ^a   Bechara, Falk G ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

basal cell carcinoma; cutaneous squamous cell carcinoma; epithelial skin cancer; microRNA; non melanoma skin cancer

Indexed keywords

MICRORNA;

ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; GENE FUNCTION; HUMAN; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; SKIN CARCINOMA;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS, BASAL CELL; SKIN NEOPLASMS;

EID: 84871568245     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0274     Document Type: Article

References (38)

1. Sand M, Gambichler T, Sand D, Skrygan M, Altmeyer P, Bechara FG. MicroRNAs and the skin: Tiny players in the body's largest organ. J Dermatol Sci. 2009;53; 169-175.
2. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006;66; 1509-1516. (Pubitemid 43259932)
3. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J. 2006;25; 522-532. (Pubitemid 43237659)
4. Caudy AA, Ketting RF, Hammond SM, Denli AM, Bathoorn AM, Tops BB, et al. A micrococcal nuclease homologue in RNAi effector complexes. Nature. 2003;425; 411-414. (Pubitemid 37187271)
5. Yoo BK, Santhekadur PK, Gredler R, Chen D, Emdad L, Bhutia S, et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology. 2011;53; 1538-1548.
6. Ratushny V, GoberMD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122; 464-472.
7. Jung GW, Metelitsa AI, Dover DC, Salopek TG. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007. Br J Dermatol. 2010;163; 146-154.
8. Jarus-Dziedzic K, ZubW, Dziedzic D, Jelen M, Krotochwil J, Mierzejewski M. Multiple metastases of carcinoma basocellulare into spinal column. J Neurooncol. 2000;48; 57-62.
9. Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, et al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest. 2010;28; 649-653.
10. Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNAinduced silencing complex (RISC) components Argonaute-1, Argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2011.
11. Lov́en J. Functional studies ofmicroRNAs in development and cancer; 2010; Department of Microbiology, Tumor and Cell Biology Karolinska Institutet, Stockholm, Sweden; http://diss. kib.ki.se/2010/978-91-7457-031-1/thesis.pdf.
12. Heffelfinger C,Ouyang Z, Engberg A, Leffell DJ, Hanlon AM, Gordon PB, et al. Correlation ofGlobalMicroRNAExpression With Basal Cell Carcinoma Subtype. G3 (Bethesda). 2012;2; 279-286.
13. Sand M, SkryganM, Sand D, Georgas D, Hahn S, Gambichler T, et al. Expression of microRNAs in basal cell carcinoma. Br J Dermatol, 2012.
14. Rowe DE, Carroll RJ, Day CL, Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26; 976-990.
15. Mohle J, Nickoloff BJ. Fatal cutaneous squamous cell carcinoma in a forty-three-year-old male. J Dermatol Surg Oncol. 1986;12; 276-279. (Pubitemid 16137919)
16. Cassarino DS,DerienzoDP, Barr RJ.Cutaneous squamous cell carcinoma: A comprehensive clinicopathologic classification. Part one. J Cutan Pathol. 2006;33; 191-206.
17. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;26; 1-26.
18. Muralidhar B, Winder D, Murray M, Palmer R, Barbosa-Morais N, Saini H, et al. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles. J Pathol. 2011;224; 496-507.
19. Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, et al. The role of microRNA in human lung squamous cell carcinoma. Cancer Genet Cytogenet. 2010;200; 127-133.
20. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, et al.MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res. 2009;15; 6192-6200.
21. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnaes E, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: A prospective translational study. Br J Cancer. 2011;104; 830-840.
22. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009;15; 3998-4008.
23. Dziunycz P, Iotzova-Weiss G, Eloranta JJ, Lauchli S, Hafner J, French LE, et al. Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. J Invest Dermatol. 2010;130; 2686-2689.
24. Yamane K, Jinnin M, Etoh T, Kobayashi Y, Shimozono N, Fukushima S, et al. Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK. J Mol Med (Berl). 2012.
25. Gu W, An J, Ye P, Zhao KN, Antonsson A. Prediction of conserved microRNAs from skin and mucosal human papillomaviruses. Arch Virol. 2011;156; 1161-1171.
26. Viarisio D, Mueller-Decker K, Kloz U, Aengeneyndt B,Kopp-Schneider A, Grone HJ, et al. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog. 2011;7; e1002125.
27. Czech MP. MicroRNAs as therapeutic targets. N Engl J Med. 2006;354; 1194-1195.
28. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005;438; 685-689.
29. Paroo Z, Ye X, Chen S, Liu Q. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell. 2009;139; 112-122.
30. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435; 828-833. (Pubitemid 40839734)
31. Al-Nakhle H, Burns PA, Cummings M, Hanby AM, Hughes TA, Satheesha S, et al. Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. Cancer Res. 2010;70; 4778-4784.
32. Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, et al.Downregulation ofmicroRNA-29c is associatedwith hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics. 2011;6; 388-394.
33. Li Y, TanW, Neo TW, Aung MO, Wasser S, Lim SG, et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 2009;100; 1234-1242.
34. Jiang LH, Q. Chang, J. Wang, E. Qiu, X. MicroRNA HSAmiR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp Lung Res.2011 Sep;37(7):387-98.
35. Cho WC, Chow AS, Au JS. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011;8; 125-131.
36. Proweller A, Tu L, Lepore JJ, Cheng L, Lu MM, Seykora J, et al. Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res. 2006;66; 7438-7444. (Pubitemid 44289196)
37. van der Schroeff JG, Evers LM, Boot AJ, Bos JL. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol. 1990;94; 423-425. (Pubitemid 20123914)
38. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284; 23204-23216.